NCT03252418

Brief Summary

Vitamin C affect the melanocytes function not the number while diode laser cause melanocytes destruction. Although diode laser and vitamin C have proved their effectiveness in depigmentation in previous studies, there are no published studies compared the effect of diode laser and vitamin C on melanocytes and melanosomes clinically and histologically.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Oct 2015

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 7, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 17, 2017

Completed
Last Updated

August 22, 2017

Status Verified

August 1, 2017

Enrollment Period

11 months

First QC Date

August 15, 2017

Last Update Submit

August 18, 2017

Conditions

Keywords

ascorbic aciddiode lasergingival hyperpigmentation

Outcome Measures

Primary Outcomes (3)

  • Dummett oral pigmentaion index (DOPI)

    scoring from 0 ( no pigmentation to 3 (sever pigmentation

    change from baseline to 1, 3 and 6 months

  • gingival brightness (ΔL)

    using spectrophotometer

    change from baseline to 1, 3 and 6 months

  • histological mean area fraction of melanosomes

    by taking soft tissue samples and stained by fontana masson stain

    change from baseline to 6 months

Secondary Outcomes (1)

  • patient satisfaction questionnaire

    immediate postopearive, 1 week, 1 month and 6 months

Study Arms (2)

ascorbic acid

EXPERIMENTAL

injection of 1 ml intamucosal ascorbic acid 3 times with 1 week interval

Drug: Ascorbic Acid 500 MG

diode laser

EXPERIMENTAL

photothermolysis by diode laser in one session

Device: diode laser

Interventions

ascorbic acid is vitamin that can cause gingival depigmentation

ascorbic acid

diode laser is soft tissue laser case photothermolysis of melanoctes

diode laser

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female patients with age ranging from 18 years old to 40 years old.
  • Bilaterally symmetric gingival hyperpigmentation on the maxillary and mandibular labial keratinized gingiva between canines.
  • Patients free from any systemic diseases as evidenced by the health questionnaire, using modified Cornell medical index (Pendleton et al., 2004).
  • Patients with thick gingival biotype ≥ 3 mm.

You may not qualify if:

  • Presence of local condition that may cause gingival hyperpigmentation (traumatized epithelium caused by defective fixed prosthesis or restoration).
  • Smokers.
  • Pregnant or lactating females.
  • Patients with poor oral hygiene, incompliance to treatment and persistence gingival inflammation after phase I periodontal therapy.
  • Clinically diagnosed periodontitis (attachment and bone loss, presence of periodontal pockets, gingival recession and tooth mobility).
  • Previous treatment to pigmentation.
  • Patients taking supplementary vitamin C for any reason.
  • Known sensitivity to ascorbic acid or any of its derivatives.
  • Patients taking any drug that may cause gingival pigmentation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Ascorbic AcidLasers, Semiconductor

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydratesLasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Nevine H kheir ElDien, Professor

    faculty of Dentistry- Ain Shams univesity

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
when measuring the gingival brightness and MAF of melanosomes
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: treating of gingival hyperpigmentation by two different methods
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer of oral medicine and periodontology

Study Record Dates

First Submitted

August 15, 2017

First Posted

August 17, 2017

Study Start

October 7, 2015

Primary Completion

September 10, 2016

Study Completion

September 10, 2016

Last Updated

August 22, 2017

Record last verified: 2017-08